Alterations in plasma hyaluronic acid in patients with clinically stable COPD versus (non)smoking controls

Hyaluronic acid (HA) is a key component of the extracellular matrix. HA and its metabolism are suggested to be altered in the lungs of patients with chronic obstructive pulmonary disease (COPD). The present study explored systemic HA, and its metabolic regulators, in patients with clinically stable...

Descripción completa

Detalles Bibliográficos
Autores principales: Waeijen-Smit, Kiki, Reynaert, Niki L., Beijers, Rosanne J. H. C. G., Houben-Wilke, Sarah, Simons, Sami O., Spruit, Martijn A., Franssen, Frits M. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342478/
https://www.ncbi.nlm.nih.gov/pubmed/34354097
http://dx.doi.org/10.1038/s41598-021-95030-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342478/
https://www.ncbi.nlm.nih.gov/pubmed/34354097
http://dx.doi.org/10.1038/s41598-021-95030-6

Ejemplares similares